Format

Send to

Choose Destination
Nat Rev Genet. 2013 Jun;14(6):415-26. doi: 10.1038/nrg3493.

Molecular genetic testing and the future of clinical genomics.

Author information

1
Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina 27710, USA. sara.katsanis@duke.edu

Abstract

Genomic technologies are reaching the point of being able to detect genetic variation in patients at high accuracy and reduced cost, offering the promise of fundamentally altering medicine. Still, although scientists and policy advisers grapple with how to interpret and how to handle the onslaught and ambiguity of genome-wide data, established and well-validated molecular technologies continue to have an important role, especially in regions of the world that have more limited access to next-generation sequencing capabilities. Here we review the range of methods currently available in a clinical setting as well as emerging approaches in clinical molecular diagnostics. In parallel, we outline implementation challenges that will be necessary to address to ensure the future of genetic medicine.

PMID:
23681062
PMCID:
PMC4461364
DOI:
10.1038/nrg3493
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center